Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
Status:
Recruiting
Trial end date:
2027-04-21
Target enrollment:
Participant gender:
Summary
This study is designed to investigate whether the use of copanlisib is safe, feasible and
beneficial to pediatric patients with solid solid tumors or lymphoma that are recurrent or
refractory to standard therapy.